Literature DB >> 29467999

The Correlation of Cardiac and Hepatic Hemosiderosis as Measured by T2*MRI Technique with Ferritin Levels and Hemochromatosis Gene Mutations in Iranian Patients with Beta Thalassemia Major.

Mohammad Soleiman Soltanpour1, Kambiz Davari2.   

Abstract

OBJECTIVES: Organ-specific hemosiderosis and iron overload complications are more serious and more frequent in some patients with beta thalassemia major (BTM) compared with others. We investigated whether coinheritance of HFE H63D or C282Y gene mutations in patients with BTM contributes to the phenotypic variation of iron overload complications and assessed the correlation of cardiac and hepatic hemosiderosis with plasma ferritin levels.
METHODS: We studied 60 patients with BTM with a mean age of 17.5±9.1 years from the Northwest of Iran. HFE gene mutations were analyzed using the polymerase chain reaction-restriction fragment length polymorphism method. Cardiac and hepatic hemosiderosis was assessed using T2*magnetic resonance imaging (MRI). Ferritin levels were measured using the enzyme immunoassay method.
RESULTS: Ferritin levels showed a strong inverse correlation with hepatic T2*MRI values (r = -0.631, p = 0.001) but a poor correlation with cardiac T2*MRI values (r = -0.297, p = 0.044). The correlation between cardiac T2*MRI values and hepatic T2*MRI values was poor and insignificant (r = 0.287, p = 0.058). Genotype and allele distribution of HFE H63D and C282Y mutation did not differ significantly between patients with and without hepatic or cardiac hemosiderosis (p > 0.050). However, carriers of HFE 63D allele had significantly higher ferritin levels compared with non-carriers (1 903±993 vs. 992±683, p < 0.001).
CONCLUSIONS: Cardiac T2*MRI values showed a poor correlation with hepatic T2*MRI values and ferritin levels. Accurate assessment of cardiac iron overload in patients with BTM can only be done using the T2*MRI technique. Additionally, HFE H63D is a significant determinant factor for elevated ferritin levels in BTM patients.

Entities:  

Keywords:  Beta Thalassemia Major; Ferritin; HFE Mutation; Hemosiderosis; Magnetic Resonance Imaging

Year:  2018        PMID: 29467999      PMCID: PMC5798798          DOI: 10.5001/omj.2018.09

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  28 in total

1.  Serum ferritin and transferrin saturation levels in β⁰ and β(+) thalassemia patients.

Authors:  I F Estevão; P Peitl Junior; C R Bonini-Domingos
Journal:  Genet Mol Res       Date:  2011-04-12

Review 2.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

3.  [HFE gene mutations in Tunisian major beta-Thalassemia and iron overload].

Authors:  F Mellouli; W El Borgi; H Kaabi; E Ben Hassen; R Sassi; H Hmida; G Cherif; M Maamar; B Zouari; K Boukef; M Bejaoui; S Hmida
Journal:  Transfus Clin Biol       Date:  2007-02-15       Impact factor: 1.406

4.  The role of HFE mutations on iron metabolism in beta-thalassemia carriers.

Authors:  Rute Martins; Isabel Picanço; Aidil Fonseca; Lídia Ferreira; Odete Rodrigues; Marília Coelho; Teresa Seixas; Armandina Miranda; Baltazar Nunes; Luciana Costa; Luísa Romão; Paula Faustino
Journal:  J Hum Genet       Date:  2004-11-05       Impact factor: 3.172

5.  Lack of association of C282Y and H63D mutations in the hemochromatosis (HFE) gene with diabetes mellitus type 2 in a case-control study of women in Brazil.

Authors:  K B Gomes; M G Carvalho; F F Coelho; I F Rodrigues; A L Soares; D A Guimarães; A P Fernandes
Journal:  Genet Mol Res       Date:  2009-10-27

6.  Frequency of Two Common HFE Gene Mutations (C282Y and H63D) in a Group of Iranian Patients With Cryptogenic Cirrhosis.

Authors:  Zahra Jowkar; Bita Geramizadeh; Mahmoud Shariat
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

7.  Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia.

Authors:  Zahra Majd; Sezaneh Haghpanah; Gholam Hossein Ajami; Sara Matin; Hamid Namazi; Marzieh Bardestani; Mehran Karimi
Journal:  Iran Red Crescent Med J       Date:  2015-04-25       Impact factor: 0.611

8.  Survey of Hfe Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study.

Authors:  Selma Unal; Günay Balta; Fatma Gümrük; Hong-Gui Xu
Journal:  Turk J Haematol       Date:  2014-09-05       Impact factor: 1.831

9.  How early can myocardial iron overload occur in beta thalassemia major?

Authors:  Gaohui Yang; Rongrong Liu; Peng Peng; Liling Long; Xinhua Zhang; Weijia Yang; Shaohong Tan; Hongfei Pan; Xingjiang Long; Taigang He; Lisa Anderson; Yongrong Lai
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Frequency of Hereditary Hemochromatosis (HFE) Gene Mutations in Egyptian Beta Thalassemia Patients and its Relation to Iron Overload.

Authors:  Azza Aboul Enein; Nermine A El Dessouky; Khalda S Mohamed; Shahira K A Botros; Mona F Abd El Gawad; Mona Hamdy; Nehal Dyaa
Journal:  Open Access Maced J Med Sci       Date:  2016-06-01
View more
  7 in total

1.  Understanding Iron Metabolism: Lessons from Transfusion-dependent Thalassemia.

Authors:  Murtadha Al-Khabori; Shahina Daar
Journal:  Oman Med J       Date:  2018-01

2.  Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes.

Authors:  Ruwangi Dissanayake; Nayana Samarasinghe; Samantha Waidyanatha; Sajeewani Pathirana; Nilaksha Neththikumara; Vajira H W Dissanayake; Kalum Wetthasinghe; Lallindra Gooneratne; Pujitha Wickramasinghe
Journal:  BMC Pediatr       Date:  2022-06-15       Impact factor: 2.567

3.  Complications and Challenges in the Management of Iraqi Patients with β-Thalassemia Major: A Single-center Experience.

Authors:  Regir K Sadullah; Sulav D Atroshi; Nasir A Al-Allawi
Journal:  Oman Med J       Date:  2020-07-27

4.  A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major.

Authors:  Arwa Khaled; Hoda A Salem; Dina A Ezzat; Hadeel M Seif; Hoda Rabee
Journal:  Drug Des Devel Ther       Date:  2019-07-22       Impact factor: 4.162

5.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

6.  Association of frequency of hereditary hemochromatosis (HFE) gene mutations (H63D and C282Y) with iron overload in beta-thalassemia major patients in Pakistan.

Authors:  Yasir Sharif; Saba Irshad; Anam Tariq; Sana Rasheed; Muhammad H Tariq
Journal:  Saudi Med J       Date:  2019-09       Impact factor: 1.484

7.  Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major.

Authors:  Arwa Khaled; Dina A Ezzat; Hoda A Salem; Hadeel M Seif; Hoda Rabee
Journal:  J Blood Med       Date:  2019-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.